Cytophage Technologies Inc. announced that it has signed a letter of intent for private placement of equity securities for gross proceeds of a minimum of $3,000,000 and a maximum of $5,000,000 on June 1, 2023. The transaction included participation from new investor, Cuspis Capital III Ltd.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.52 CAD | +6.12% | +11.83% | -26.20% |
27/05 | Cytophage Technologies Ltd. Strengthens Board of Directors | CI |
30/04 | Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-26.20% | 15.37M | |
+41.59% | 739B | |
+32.36% | 598B | |
-5.25% | 353B | |
+17.56% | 318B | |
+4.67% | 285B | |
+16.58% | 240B | |
+9.63% | 210B | |
-5.19% | 206B | |
+7.57% | 164B |
- Stock Market
- Equities
- CYTO Stock
- News Cytophage Technologies Ltd.
- Cytophage Technologies Inc. announced that it expects to receive $5 million in funding from Cuspis Capital III Ltd.